arrow The biopharmaceutical company Emergent Biosolutions, where a mishap spoiled 15 million doses of Johnson & Johnson s COVID vaccine, in Baltimore, Maryland, April 1, 2021. JIM LO SCALZO/EPA-EFE/Shutterstock
New York and New Jersey officials are monitoring the situation with Johnson & Johnson, after reports of a production delay with the drugmaker s COVID-19 vaccine. The single shot from the New Jersey-based company is vital to New York’s vaccination expansion, especially for reaching vulnerable populations such as homebound seniors and the homeless.
The New York Times reported Wednesday that a mix-up by a manufacturing partner in Baltimore Emergent Biosolutions had damaged 15 million doses of the vaccine, adding that the error does not impact any current doses in circulation.